StockData
Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc. (EWTX) stock

EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$42.04−1.64 (-3.75%)

Close on Nov 17, 2026Market cap $4.57BP/E –Yield –

Edgewise Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Edgewise Therapeutics's total debt was $7.00K at Sep 30, 2022.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$7.00K–

More Edgewise Therapeutics figures

See a number that looks wrong?